Targeting joint health and eye health through condition-specific dietary supplement formulas, Valensa International, Eustis, FL, has reached an exclusive agreement with Aker BioMarine ASA, Oslo, Norway, to use Aker BioMarine’s Superba krill oil. Valensa plans on using the highly bioavailable omega 3 phospholipids of Superba krill oil in conjunction with several of its own proprietary ingredients, such as Zanthin natural astaxanthin, extending its current platform of patented and patent-pending formulations. In November, Valensa terminated a similar agreement it forged with Neptune Technologies & Bioressources.